US EditionTrump’s Demand to Trading Partners: Pledge Money or Get Higher Tariffs | Chattanooga Times Free Press
UNITED STATES, AUG 5 – Pharmaceutical companies including AstraZeneca and Johnson & Johnson pledge over $250 billion to boost U.S. manufacturing amid tariff threats intended to reduce foreign drug dependence.
5 Articles
5 Articles
Trump threatens to ratchet up tariffs on EU if it fails to invest $600 billion in US
President Trump warned that if the European Union fails to deliver on its commitment to invest $600 billion in the US, then he will ramp up tariffs against the 27-nation bloc.
Trump’s demand to trading partners: Pledge money or get higher tariffs | Chattanooga Times Free Press
President Donald Trump’s tariff threats have turned into a play for cold, hard cash as he tries to leverage U.S. economic power to cajole other nations to make multibillion-dollar investments in order to maintain access to America’s market.
Drugmakers pledge $250 billion for US manufacturing amid Trump tariff threats
President Donald Trump's warnings about pharmaceutical tariffs have triggered a wave of manufacturing commitments from major drugmakers. AstraZeneca announced $50 billion for US expansion, Johnson & Johnson pledged $55 billion for domestic production and research, while Eli Lilly committed $27 billion for four new plants. Industry analysts calculate these planned investments now exceed $250 billion total. Trump argues these moves will strengthen…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
